Sale!

ATP1A2 Gene Familial hemiplegic migraine type 2 Genetic Test

4,400 د.إ

-21%

The ATP1A2 gene plays a crucial role in the proper functioning of brain cells. Mutations in this gene are associated with familial hemiplegic migraine type 2 (FHM2), a rare form of migraine characterized by severe headache accompanied by temporary paralysis on one side of the body (hemiplegia), sensory disturbances, and, in some cases, coma or seizure-like episodes. These symptoms are much more severe than those of a typical migraine.

To diagnose this condition accurately, genetic testing is available at DNA Labs UAE, which specifically looks for mutations in the ATP1A2 gene. This test is vital for individuals with a family history of FHM2 or those who exhibit symptoms suggestive of this condition. By identifying mutations in the ATP1A2 gene, healthcare providers can confirm a diagnosis of familial hemiplegic migraine type 2, which can significantly aid in the management and treatment of the condition.

The cost of the ATP1A2 gene familial hemiplegic migraine type 2 genetic test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted by healthcare professionals who specialize in genetic testing, ensuring accurate and reliable results. Opting for this test at DNA Labs UAE not only provides individuals with a definitive diagnosis but also helps in understanding the genetic basis of their condition, which is crucial for making informed decisions about treatment and management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test

Introduction

The ATP1A2 gene is associated with familial hemiplegic migraine type 2 (FHM2), a rare genetic disorder characterized by severe headaches that are accompanied by temporary paralysis on one side of the body. The ATP1A2 gene provides instructions for making a protein called the Na+/K+ ATPase alpha-2 subunit, which is involved in the transport of sodium and potassium ions across cell membranes. Mutations in the ATP1A2 gene can disrupt the normal functioning of this protein, leading to altered ion transport and changes in the excitability of neurons in the brain, which can trigger migraines.

Test Components and Price

  • Test Name: ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test
  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for ATP1A2 Gene Familial Hemiplegic Migraine Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A2 Gene Familial Hemiplegic Migraine Type 2.

Test Details

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the ATP1A2 gene that are associated with FHM2. This type of genetic testing uses advanced sequencing technologies to rapidly analyze large amounts of DNA, allowing for the detection of subtle genetic changes that may be missed by other testing methods. NGS genetic testing can provide a definitive diagnosis of FHM2, which can help guide treatment and management strategies for affected individuals and their families.

Test Name ATP1A2 Gene Familial hemiplegic migraine type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATP1A2 Gene Familial hemiplegic migraine type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A2 Gene Familial hemiplegic migraine type 2
Test Details

The ATP1A2 gene is associated with familial hemiplegic migraine type 2 (FHM2), a rare genetic disorder characterized by severe headaches that are accompanied by temporary paralysis on one side of the body. The ATP1A2 gene provides instructions for making a protein called the Na+/K+ ATPase alpha-2 subunit, which is involved in the transport of sodium and potassium ions across cell membranes. Mutations in the ATP1A2 gene can disrupt the normal functioning of this protein, leading to altered ion transport and changes in the excitability of neurons in the brain, which can trigger migraines.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the ATP1A2 gene that are associated with FHM2. This type of genetic testing uses advanced sequencing technologies to rapidly analyze large amounts of DNA, allowing for the detection of subtle genetic changes that may be missed by other testing methods. NGS genetic testing can provide a definitive diagnosis of FHM2, which can help guide treatment and management strategies for affected individuals and their families.